Makrosky
Member
- Joined
- Oct 5, 2014
- Messages
- 3,982
I don't know if you are aware of what happened lately in France with a Phase 1 clinical trial of a compound (BIA 10-2474) which inhibits the enzyme responsible of degradation of some endogenous cannabinoids.
1 healthy individual died and 4 other healthy ones are in comma.
(http://www.sciencemag.org/news/2016/01/more-details-emerge-fateful-french-drug-trial)
I haven't found info on which animals did they choose for the pre-clinical phase (before Phase 1) but most probably it was mice. Considering the Phase 1 usually starts with a very reduced ammount for safety and intraspecies differences you can see how big the differences can be from mice to humans.
The final explanation of what happened hasn't been released yet. We'll see....
1 healthy individual died and 4 other healthy ones are in comma.
(http://www.sciencemag.org/news/2016/01/more-details-emerge-fateful-french-drug-trial)
I haven't found info on which animals did they choose for the pre-clinical phase (before Phase 1) but most probably it was mice. Considering the Phase 1 usually starts with a very reduced ammount for safety and intraspecies differences you can see how big the differences can be from mice to humans.
The final explanation of what happened hasn't been released yet. We'll see....